.
MergerLinks Header Logo

New Deal


Announced

R-Biopharm to acquire AusDiagnostics.

Synopsis

R-Biopharm, a provider of diagnostic technologies and products, agreed to acquire AusDiagnostics, a designer and manufacturer of diagnostic and testing equipments. Financial terms were not disclosed. “The existing and future molecular biology multiplex analysis platforms for syndrome testing from system supplier AusDiagnostics broadens our molecular biology expertise and perfectly complements our present clinical diagnostics portfolio. The acquisition strengthens our position as a reliable partner for system solutions and offers our customers additional options for diagnostics," Christian Dreher, R-Biopharm CEO.

Show Details & Financials

Market Context

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US